Park Avenue Securities LLC Annexon, Inc. Transaction History

Park Avenue Securities LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	BUY	$1.38 - $2.73 $41,400 - $81,900	30,000 Added 36.11%	113,068 $271,000
Q1 2025 Apr 14, 2025	SELL	$1.93 - $5.5 $67,550 - $192,500	-35,000 Reduced 29.64%	83,068 $160,000
Q3 2024 Oct 03, 2024	BUY	$4.49 - $7.2 $305,688 - $490,190	68,082 Added 136.2%	118,068 $699,000
Q2 2024 Jul 09, 2024	BUY	$4.33 - $6.79 $216,439 - $339,404	49,986 New	49,986 $245,000

151

101M

88.6K

32.5K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $136M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.